Arterial hypertension and diabetes are chronic pathological conditions presenting with a very high frequency in the adult general population.
Pathogenic Clues
There are several possible explanations for the unexpectedly high frequency of such co-morbidity. The progressive vascular damage seen in chronic hyperglycaemia is associated with the development of earlier and more severe atherosclerosis, with accelerated age-related arterial stiffening and increased systolic hypertension, as well as with microvascular damage, particularly in the kidney. Furthermore, hyperglycaemia and/or the hyperinsulinaemic state of type 2 diabetes may be responsible for sodium retention and volume expansion, thus increasing sodium sensitivity and blood pressure. On the other hand, it has also been proposed that hypertension-associated factors, such as increased sympathetic and/or renin-angiotensin activity, may favour the development of insulin resistance by limiting the access of insulin and glucose to skeletal muscle, the primary site of insulin-mediated glucose uptake. However, the association of hypertension and diabetes may reflect the existence of common underlying mechanism(s), either genetic or environmental. In this respect, obesity and insulin resistance are the two most relevant factors, often clustered in the so-called metabolic syndrome.
Over the last few years, obesity has reached epidemic proportions: more than 1 billion adults are currently overweight and at least 300 million of them are clinically obese. By 2030, the respective number of overweight and obese adults is projected to be 1.35 billion and 573 million individuals (or even 2.16 billion overweight and 1.12 billion obese individuals, if recent secular trends continue unabated). 4 In parallel, the total number of people with diabetes is projected to rise to 366 million in 2030. A new term has been coined to describe the incoming healthcare crisis: the diabesity epidemic. 
Endocrine Hypertension
There are several endocrine diseases that are associated with the development of high blood pressure. Sometimes, arterial hypertension is the condition prompting the patient to seek medical advice, and it is very important to always take into account these forms of secondary hypertension in the diagnostic work-up.
Primary Aldosteronism
The most frequent condition is certainly primary aldosteronism; its prevalence varies according to the criteria adopted for diagnosis (up to 10% of the general hypertensive population). High blood pressure is almost invariably part of the syndrome 15 and in many cases highgrade (2 and 3) and/or resistant hypertension (defined as failure to achieve goal blood pressure despite adherence to an appropriate three-drug regimen including a diuretic) is present.
The elevation in blood pressure is dependent on mild volume expansion and an increase in systemic vascular resistance in the presence of excess mineralocorticoid activity.
The first step for the diagnosis of primary aldosteronism is measurement of the aldosterone:renin ratio, followed by a confirmatory biochemical test (oral sodium loading, saline infusion, fludrocortisone suppression or captopril challenge; see Figure 1 ). 16 however, pharmacological antihypertensive treatment may be necessary for a prolonged period or even indefinitely in these patients.
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Pheochromocytoma
The Cardiovascular Risk 
Thyroid Disease
Hypertension is present in many cases of hyper-or hypothyroidism. 
Hyperparathyroidism
Blood pressure increase is frequently seen in association with primary hyperparathyroidism, even among those with mild disease. 24 The mechanisms underlying this association are poorly understood and the causal relationship has been questioned. 
Conclusions
Arterial hypertension is a common feature in diabetes and several other endocrine syndromes. An increase in blood pressure can be produced by many different mechanisms and often substantially contributes to the morbidity and mortality of these diseases. As a consequence, early diagnosis and appropriate treatment may significantly affect the prognosis in these patients. n
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